Table 1 Patient and tumor characteristics of samples in the study
From: Gene expression profiling of the tumor microenvironment during breast cancer progression
Patient number | Age (years) | Grade | Estrogen receptor | Progesterone receptor | Her-2 | Size | Nodal status | Tumor type |
|---|---|---|---|---|---|---|---|---|
44 | 28 | III | Positive | Positive | Negative | 1 | Negative | Ductal |
45 | 36 | I | Positive | Positive | Negative | N/A | Negative | Ductal |
79 | 54 | I | Positive | Positive | Negative | 2.1 | Positive | Ductal |
96 | 31 | III | Negative | Negative | Negative | 3.7 | Negative | Ductal |
102 | 55 | I | Positive | Negative | Negative | 5.2 | Positive | Ductal |
121 | 45 | II | Positive | Positive | Positive | 1.5 | Positive | Ductal |
131 | 37 | II | Positive | Positive | Positive | 1.5 | Positive | Ductal |
133 | 44 | III | Negative | Negative | Positive | 1.5 | Positive | Ductal |
148 | 42 | II | Positive | Positive | Negative | 1.9 | Positive | Ductal |
153 | 46 | I | Positive | Positive | ND | N/A | Positive | Ductal |
169 | 34 | II | Positive | Positive | Negative | 2.6 | Positive | Ductal |
178 | 43 | III | Positive | Positive | Positive | 2.8 | Positive | Ductal |
179 | 37 | III | Negative | Negative | Positive | 1.5 | Positive | Ductal |
180 | 46 | I | Positive | Positive | Negative | 1.9 | Positive | Ductal |